Neurology
ALS Drug Relyvrio May Be Pulled From Market
Manufacturer may pull medication from the market following lackluster results from a large trial
Degenerative Cervical Myelopathy Patients Often Have Severe Residual Paresthesia
Residual paresthesia tied to significantly worse treatment satisfaction, even after accounting for quality of life
AAN: Three Pesticides Linked to Risk for Parkinson Disease
Highest versus lowest decile of application of simazine, lindane, atrazine linked to increased relative risks for Parkinson disease
Overall Stroke Rates Down, but Hemorrhagic Stroke Up in Recent Years
Overall stroke mortality decline slowed, with variations seen by age and region
Link Between Sleep Apnea, Incident Stroke Examined for Blacks, Whites
Among Whites, high OSA risk, provider-diagnosed sleep apnea, and PAP treatment linked to increased risk for incident stroke
FDA Delays Decision on New Alzheimer’s Drug
FDA Approves Wegovy to Lower Risk for CVD Events in Patients With Obesity
Agency's action could widen access to the drug if more insurance companies decide to cover it
AAN: Dementia More Common With Essential Tremor Than in the General Population
However, dementia rates lower than a comparison cohort of people with Parkinson disease
Risk for MI, Stroke, Death Increased With Plastics in Carotid Plaques
Risk for primary end-point event higher in patients in whom microplastics and nanoplastics were detected within the atheroma
Morphology of Vestibular Aqueduct Linked to Meniere Disease
Correlations seen for VA patency and length with the degree of endolymphatic hydrops in cochlear, vestibule